Efficacy and Safety of IncobotulinumtoxinA for the Treatment of Blepharospasm: A Multicenter, Phase 3 Study in Japan

This open-label, uncontrolled, single-arm, multicenter, phase 3 study evaluated the efficacy and safety of incobotulinumtoxinA in Japanese patients with blepharospasm. Eligible patients received incobotulinumtoxinA injections at fixed doses (50, 75, or 100 units [U] for those who had previously rece...

Description complète

Détails bibliographiques

Auteurs principaux:	Toshiaki Goseki, Yoshihito Mochizuki, Akiko Masuda, Motohiro Kiyosawa, Ryosuke Miyamoto, Masato Wakakura, Akiko Yamagami, Yohei Mukai, Akihiro Shinkai, Mutsumi Iijima, Kousuke Baba, Hideki Chuman, Masahiro Hashizuka, Shohei Tateishi, Akiko Kimura
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2026-02-01
Collection:	Toxins
Sujets:	blepharospasm botulinum toxin dystonia East Asia efficacy incobotulinumtoxinA
Accès en ligne:	https://www.mdpi.com/2072-6651/18/2/109
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!